Metropolitan Life Insurance Company (MetLife)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $159K | Buy |
|
|||||
|
2023
Q1 | $136K | Sell |
|
|||||
|
2022
Q4 | $67.8K | Hold |
|
|||||
|
2022
Q3 | $44.9K | Hold |
|
|||||
|
2022
Q2 | $54.2K | Hold |
|
|||||
|
2022
Q1 | $58.5K | Sell |
|
|||||
|
2021
Q4 | $199K | Hold |
|
|||||
|
2021
Q3 | $758K | Buy |
|
|||||
|
2021
Q2 | $1.07M | Buy |
|
|||||
|
2021
Q1 | $175K | Buy |
|
|||||
|
2020
Q4 | $208K | Sell |
|
|||||
|
2020
Q3 | $167K | Sell |
|
|||||
|
2020
Q2 | $271K | Sell |
|
|||||
|
2020
Q1 | $993K | Buy |
|
|||||
|
2019
Q4 | $1.39M | Buy |
|
|||||
|
2019
Q3 | $530K | Buy |
|
|||||
|
2019
Q2 | $583K | Buy |
|
|||||
|
2019
Q1 | $519K | Hold |
|
|||||
|
2018
Q4 | $341K | Hold |
|
|||||
|
2018
Q3 | $496K | Buy |
|
|||||
|
2018
Q2 | $191K | Buy |
|
|||||
|
2018
Q1 | $73.1K | Hold |
|
|||||
|
2017
Q4 | $101K | Sell |
|
|||||
|
2017
Q3 | $202K | Hold |
|
|||||
|
2017
Q2 | $205K | Buy |
|